Johnson & Johnson announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommends the approval of an indication extension of TALVEY® ...

Subgroup analysis of patients who received Bruton Tyrosine Kinase inhibitor (BTKi) treatment immediately prior to iopofosine I 131 achieved 87.5% ORR, 79.2% MRR and 100% CBR with median DOR of 16 ...

Subgroup analysis of patients who received Bruton Tyrosine Kinase inhibitor (BTKi) treatment immediately prior to iopofosine I 131 achieved 87.5% ...

Topline results expected mid-December 2026REDWOOD CITY, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (Rezolute or ...

A cough that lasts for 8 weeks or longer is called a "chronic cough." The cause is not necessarily limited to one thing, so it is narrowed down through examinations and tests.Initial Consultation and ...

Get IFGL Refractories latest Profit & Loss account, Income Statement, Financial Statements and IFGL Refractories detailed profit and loss accounts including income, expenses, and net profit. Get ...

The novel oral helicase-primase inhibitor offers a non-intravenous option for immunocompromised adults with mucocutaneous HSV refractory to standard antivirals.

Boost ROI through application diversification, advanced processing, sustainable mining, digital supply chains and strategic partnerships that reduce costs and expand global reach.Dublin, Oct. 13, 2026 ...

The inside of blast furnaces and converters at steel mills is a world that easily exceeds 1,000°C. The materials that protect ...

An 86-year-old woman presented to the emergency department with 12 days of persistent nausea, poor oral intake, and weight ...

Insimbi Industrial Holdings Limited provided earnings guidance for the six month period ended 31 August 2026. For the year, with earnings per share ("EPS") expected to be in a profit positive ...